These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10838448)

  • 41. Alloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicity.
    Oldenburg J; Lacroix-Desmazes S; Lillicrap D
    Haematologica; 2015 Feb; 100(2):149-56. PubMed ID: 25638804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of FEIBA and Amicar in the operating room--dental treatment of a patient with hemophilia and high titer factor VIII inhibitors.
    Sharp HK; McIlveen LP; Schuman NJ
    Spec Care Dentist; 1986; 6(5):210-2. PubMed ID: 2945270
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacokinetics of ε-Aminocaproic Acid in Neonates Undergoing Cardiac Surgery with Cardiopulmonary Bypass.
    Eaton MP; Alfieris GM; Sweeney DM; Angona RE; Cholette JM; Venuto C; Anderson B
    Anesthesiology; 2015 May; 122(5):1002-9. PubMed ID: 25723765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epsilon-aminocaproic acid (EACA).
    Griffin JD; Ellman L
    Semin Thromb Hemost; 1978; 5(1):27-40. PubMed ID: 568312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitors in haemophilia A: current management and open issues.
    Haya S; Moret A; Cid AR; Cortina V; Casaña P; Cabrera N; Aznar JA
    Haemophilia; 2007 Dec; 13 Suppl 5():52-60. PubMed ID: 18078398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics and pharmacodynamics of epsilon-aminocaproic acid in horses.
    Ross J; Dallap BL; Dolente BA; Sweeney RW
    Am J Vet Res; 2007 Sep; 68(9):1016-21. PubMed ID: 17764418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan.
    Shirahata A; Fukutake K; Higasa S; Mimaya J; Oka T; Shima M; Takamatsu J; Taki M; Taneichi M; Yoshioka A;
    Haemophilia; 2011 Sep; 17(5):771-6. PubMed ID: 21682824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Population pharmacokinetics of epsilon-aminocaproic acid in infants undergoing craniofacial reconstruction surgery.
    Stricker PA; Zuppa AF; Fiadjoe JE; Maxwell LG; Sussman EM; Pruitt EY; Goebel TK; Gastonguay MR; Taylor JA; Bartlett SP; Schreiner MS
    Br J Anaesth; 2013 May; 110(5):788-99. PubMed ID: 23353035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Domiciliary desensitization therapy for young boys with haemophilia and factor VIII inhibitors.
    Lilleyman JS
    Br J Haematol; 1994 Feb; 86(2):433-5. PubMed ID: 8199043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epsilon-Aminocaproic Acid Has No Association With Thromboembolic Complications, Renal Failure, or Mortality After Liver Transplantation.
    Nicolau-Raducu R; Ku TC; Ganier DR; Evans BM; Koveleskie J; Daly WJ; Fish B; Cohen AJ; Reichman TW; Bohorquez HE; Bruce DS; Carmody IC; Loss GE; Gitman M; Marshall T; Nossaman BD
    J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):917-23. PubMed ID: 27020101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitor development in haemophilia A patients with inversion of the intron 22 of the factor VIII gene.
    Tizzano EF; Altisent C; Domènech M; Cornet M; Tusell J; Baiget M
    Thromb Haemost; 1996 Jul; 76(1):125-6. PubMed ID: 8819266
    [No Abstract]   [Full Text] [Related]  

  • 52. Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.
    Lu J; Meng H; Meng Z; Sun Y; Pribis JP; Zhu C; Li Q
    Int J Clin Exp Pathol; 2015; 8(7):7978-87. PubMed ID: 26339364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factor VIII antibody in a patient with mild haemophilia.
    Bovill EG; Burns SL; Golden EA
    Br J Haematol; 1985 Oct; 61(2):323-8. PubMed ID: 3929830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The evidence behind inhibitor treatment with porcine factor VIII.
    Lee CA
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():5-8. PubMed ID: 12214138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The prevalence of proteolytic antibodies against factor VIII in hemophilia A.
    Lacroix-Desmazes S; Bayry J; Misra N; Horn MP; Villard S; Pashov A; Stieltjes N; d'Oiron R; Saint-Remy JM; Hoebeke J; Kazatchkine MD; Reinbolt J; Mohanty D; Kaveri SV
    N Engl J Med; 2002 Feb; 346(9):662-7. PubMed ID: 11870243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factor VIII inhibitors in patients with hemophilia A: epidemiology of inhibitor development and induction of immune tolerance for factor VIII.
    Kreuz W; Becker S; Lenz E; Martinez-Saguer I; Escuriola-Ettingshausen C; Funk M; Ehrenforth S; Auerswald G; Kornhuber B
    Semin Thromb Hemost; 1995; 21(4):382-9. PubMed ID: 8747701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pattern of factor VIII inhibitors in patients with hemophilia A in the north east of Iran.
    Modaresi AR; Torghabeh HM; Pourfathollah AA; Shooshtari MM; Yazdi ZR
    Hematology; 2006 Jun; 11(3):215-7. PubMed ID: 17325965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinically significant inhibitors in hemophilia A patients from India tend to persist.
    Shetty S; Ghosh K; Pathare A; Mohanty D
    Acta Haematol; 2000; 103(3):175-6. PubMed ID: 10940659
    [No Abstract]   [Full Text] [Related]  

  • 59. Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.
    Luna-Záizar H; Beltrán-Miranda CP; Esparza-Flores MA; Soto-Padilla J; Bergés-García A; Rodríguez-Zepeda MD; Pompa-Garza MT; Jaloma-Cruz AR
    Haemophilia; 2014 Jan; 20(1):e7-14. PubMed ID: 24354488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of antiproteolytic drugs: epsilon-aminocaproic acid (EACA) and aprotinin on experimental anti-GBM nephritis.
    Hruby Z; Wendycz D; Kopeć W; Czerchawski L; Józefowiak M; Rabczyński J
    Nephrol Dial Transplant; 1996 Jan; 11(1):32-9. PubMed ID: 8649650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.